The OpenLoop Health data breach (January 2026) affected ~1.6 million records including MEDVi patients
Kevin Sheng-Kai Ma, DDS, FRSPH, FRSM, international scholar at the Center for Global Health at the Perelman School of Medicine at the University of Pennsylvania and lead author of this study, told Medical News Today that he and his colleagues were not surprised by these findings, as these [obesity and obesity-related issues] are indications for GLP-1RA that have been approved in recent years. That said, clinicians are encouraged to monitor and continue assessing patients receiving GLP-1RA [drugs], he advised
What is the recommendation you all give to the younger population to start monitoring their own heart health to know whether they need help
Treatment decisions should be made by patients and their healthcare providers. To land on the banned list, a substance has to satisfy two of three criteria: The potential to enhance sport performance
The key question isnt if plans cover GLP-1sits how tightly they manage them
Steven Heymsfield et al noted that many factors can influence individual changes in FFM relative to weight lossincluding dietary intake, physical activity, aging, the metabolic and hormonal stateand individual factors like adiposity, race, and sex. Tracking body composition changes during GLP-1 receptor agonist induced weight loss has become increasingly needed in the context of muscle tissue loss